Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Dose Finding Study of HP802-247 in Venous Leg Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of HP802-247 in Venous Leg Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852995).
- Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence…
- Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Dose Optimization Trial of CD19 Redirected Autologous T Cells: Complete Statistical AnalysisIndependent statistical analysis of Dose Optimization Trial of CD19 Redirected Autologous T Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747486).
- Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Ranging Study – Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): primary endpoint results,…
- Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: primary endpoint results, effect estimate with…
- Dose Response of Ketorolac in Knee Arthroscopy: Complete Statistical AnalysisIndependent statistical analysis of Dose Response of Ketorolac in Knee Arthroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02181426).
- Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis: Complete Statistical AnalysisIndependent statistical analysis of Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose the Saline Reduce the Mucus Production When Water Exchange Colonoscopy is Used?: Complete Statistical AnalysisIndependent statistical analysis of Dose the Saline Reduce the Mucus Production When Water Exchange Colonoscopy is Used?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men: Complete Statistical AnalysisIndependent statistical analysis of Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dose-Escalation Safety and Pharmacokinetic Study of K305: Complete Statistical AnalysisIndependent statistical analysis of Dose-Escalation Safety and Pharmacokinetic Study of K305: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01304316).
- Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01068912).
- Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD): Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence…
- Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02160626).
- Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01793610).
- Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DoseFlexIndependent statistical analysis of Dosing Flexibility Study in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580840).
- Dosing of Levetiracetam (Keppra) in Neonates: Complete Statistical AnalysisIndependent statistical analysis of Dosing of Levetiracetam (Keppra) in Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01239212).
- Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe): Complete Statistical AnalysisIndependent statistical analysis of Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe): primary endpoint results, effect estimate with confidence…
- Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders: Complete Statistical AnalysisIndependent statistical analysis of Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843): Complete Statistical AnalysisIndependent statistical analysis of Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843): primary endpoint results, effect estimate with confidence interval,…
- Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma: Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia (“PRO-SID” Study): Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study): primary endpoint results,…
- Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01753713).
- Down Syndrome Memantine Follow-up Study: Complete Statistical AnalysisIndependent statistical analysis of Down Syndrome Memantine Follow-up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02304302).
- Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy: primary endpoint results, effect estimate with confidence…
- Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin’s Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…